Skip to content

Is this US tech stock going to be the Microsoft of Big Data?


When we first wrote about this tech stock over two years ago it was more or less a pipe dream of its very extreme sounding CEO and its famous chairman. It was trading at $24-25 at the time with a much larger market cap.

This stock was embedded in the Big Data story even before the AI craze took hold and it is looking even more attractive now. Two years later it is still standing proudly defending the western lifestyle of freedom – I personally like the direction the management team is taking, and reckon they have one of the smartest CEOs in the tech sector right now.

SPAC entry instead of normal IPO

This stock pick tracks my personal program to  build a portfolio of US listed stocks and manage them accordingly. My third stock to enter my list interesting stocks in the US stock market has been one of the most controversial SPACs stocks to his Wall Street especially as many big US players do not like it, because they lost their usual IPO revenue.

Readers will recall the SPAC (Special Purpose Acquisition Company) period was 2020: 427 SPACs with $80 billion invested and in 2021 613. It was a golden era for cash shells.

The SPAC BOOM 2020-2021

The SPAC had a $10 open price and had to buy a company inside two years or the money was going to be returned to investor. In the end lot of rush deals where completed. Wall Street investment bankers did not like SPACs because they lost a lot of money as companies entered the US stock market without them. This company was among the better prospects to hit the US market as a consequence of this opportunity.

Want the full story? Access all of The Armchair Trader's content for just £5.99 per month.

Get weekly investment ideas and tips that will take your investing to the next level. Sign up here.

Free 28 day trial. Cancel anytime.

Log In or Sign Up to Armchair Trader+

Already a member? Log in here:

Not a member yet? Sign up for your free trial or check out the benefits of membership.

Further content of this article is not available as it is for members only. Please visit the registration page for Armchair Trader Plus+ for further details on the benefits of becoming a member.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top